Previous close | 119.40 |
Open | 124.36 |
Bid | 121.30 x N/A |
Ask | 127.52 x N/A |
Day's range | 122.12 - 126.40 |
52-week range | 62.55 - 142.32 |
Volume | |
Avg. volume | 18,428 |
Market cap | 60.487B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 46.42 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insightful Analysis of Moderna's Financial Health and Strategic Position
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.